Open access
Open access
Powered by Google Translator Translator

Nephrology

Microhematuria: AUA/SUFU Guideline

2 Jul, 2020 | 08:38h | UTC

Microhematuria: AUA/SUFU Guideline – American Urological Association

News Release: Leading Organizations Release Joint Clinical Guideline For Diagnosis And Evaluation Of Microhematuria – American Urological Association

 


Guideline Summary: Major Consensus Statement on IV Contrast Nephropathy

1 Jul, 2020 | 07:33h | UTC

Major Consensus Statement on IV Contrast Nephropathy – Journal Feed

Original Guideline: ACR/NKF Consensus Statement: “The Risk of Acute Kidney Injury Developing in Patients with Reduced Kidney Function Following Exposure to Intravenous Iodinated Contrast Media has Been Overstated” (Guideline and commentaries)

 


[Abstract Only] Randomized Trial: Serum Urate Lowering with Allopurinol Does Not Improve Kidney Function in Type 1 Diabetes

26 Jun, 2020 | 09:03h | UTC

Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes – New England Journal of Medicine

Commentaries: Despite Lowering Serum Urate Levels, Allopurinol Does Not Slow Kidney Decline in Type 1 Diabete – Physician`s Weekly AND Does Lowering Uric Acid With Allopurinol Slow Progression Of Chronic Kidney Disease? – MedicalResearch.com AND Study finds promising treatment to slow kidney disease doesn’t prove out in clinical trial – University of Minnesota Medical School

 


AHA/AMA Joint Policy Statement: Self-Measured Blood Pressure Monitoring at Home

23 Jun, 2020 | 08:24h | UTC

Self-Measured Blood Pressure Monitoring at Home: A Joint Policy Statement from the American Heart Association and American Medical Association – Circulation

News Release: American Heart Association and American Medical Association urge broader adoption of self-measured blood pressure monitoring – American Medical Association

 


Review: Acute Kidney Injury in Critically ill Patients with COVID-19

15 Jun, 2020 | 03:41h | UTC

Acute kidney injury in critically ill patients with COVID-19 – Intensive Care Medicine

 


Characterization of Acute Kidney Injury in Critically Ill Patients with Severe Coronavirus Disease 2019

9 Jun, 2020 | 04:41h | UTC

Characterization of acute kidney injury in critically ill patients with severe coronavirus disease 2019 – Clinical Kidney Journal

Commentary: Acute kidney disease in critically ill COVID-19 patients – ERA-EDTA

 


Unruptured Intracranial Aneurysms: Pathogenesis and Individualized Management

1 Jun, 2020 | 03:39h | UTC

Unruptured Intracranial Aneurysms: Pathogenesis and individualized management – Deutsches Ärzteblatt International

 


[Abstract Only] Study: Primary Aldosteronism Common and Largely Unrecognized in Patients with Hypertension

1 Jun, 2020 | 03:41h | UTC

The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study – Annals of Internal Medicine (link to abstract – $ for full-text)

Commentary: Aldosterone production is a common and unrecognized cause of high blood pressure – American College of Physicians

 


A Deep Learning Algorithm to Detect Chronic Kidney Disease from Retinal Photographs

29 May, 2020 | 03:02h | UTC

A deep learning algorithm to detect chronic kidney disease from retinal photographs in community-based populations – The Lancet Digital Health

Commentary: Opportunistic deep learning of retinal photographs: the window to the body revisited – The Lancet Digital Health

 

Related Commentary on Twitter

 


Meta-Analysis: ACEI/ARB Use and Risk of Infection or Severity or Mortality of COVID-19

20 May, 2020 | 09:50h | UTC

ACEI/ARB Use and Risk of Infection or Severity or Mortality of COVID-19: A Systematic Review and Meta-analysis – Pharmacological Research

Related Study (Preprint): Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers with the Risk of Hospitalization and Death in Hypertensive Patients with Coronavirus Disease-19 – medRxiv

 


Management of Acute Kidney Injury in Patients with COVID-19

19 May, 2020 | 04:40h | UTC

Management of acute kidney injury in patients with COVID-19 – The Lancet Respiratory Medicine

Related: Acute Kidney Injury In Patients Hospitalized With Covid-19 – Kidney International

 


New NICE Covid-19 Rapid Guidelines: Chronic Kidney Disease & Interstitial Lung Disease

18 May, 2020 | 02:15h | UTC

COVID-19 rapid guideline: chronic kidney disease – National Institute for Health and Care Excellence

COVID-19 rapid guideline: interstitial lung disease – National Institute for Health and Care Excellence

See also: Complete Collection of Covid-19 Rapid Guidelines

 


Meta-Analysis: Furosemide Stress Test as a Predictive Marker of Acute Kidney Injury Progression or Renal Replacement Therapy

11 May, 2020 | 00:12h | UTC

Furosemide stress test as a predictive marker of acute kidney injury progression or renal replacement therapy: a systemic review and meta-analysis – Critical Care

 


NICE COVID-19 Guideline: Acute Kidney Injury in Hospital

7 May, 2020 | 09:30h | UTC

COVID-19 rapid guideline: acute kidney injury in hospital – National Institute for Health and Care Excellence

 


2020 International Society of Hypertension Global Hypertension Practice Guidelines

7 May, 2020 | 09:00h | UTC

2020 International Society of Hypertension Global Hypertension Practice Guidelines – Hypertension

 


Cohort Study: SLGT2 Inhibitors Linked to Lower Risk of Renal Events in Patients with Type 2 Diabetes

7 May, 2020 | 08:57h | UTC

Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study – The BMJ

Editorial: SGLT2 inhibitors and kidney outcomes in the real world

Commentary: Certain diabetes drugs may protect against serious kidney problems – The BMJ

Related Analysis: Communicating emerging risks of SGLT2 inhibitors—timeliness and transparency of medicine regulators – The BMJ

 


New Observational Studies Confirm the Safety of Renin–Angiotensin–Aldosterone System Blockers in Patients with Covid-19

3 May, 2020 | 22:32h | UTC

Editorial: Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19 – New England Journal of Medicine

Study 1: Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19 – New England Journal of Medicine

Study 2: Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 – New England Journal of Medicine

Study 3: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 – New England Journal of Medicine

Study 4: Effects Of ARBs And ACEIs On Virus Infection, Inflammatory Status And Clinical Outcomes In COVID-19 Patients With Hypertension: A Single Center Retrospective Study – Hypertension

Commentary: Blood Pressure Drugs Don’t Increase Coronavirus Risk, Studies Find – The New York Times

See also: Observational Study: Renin-Angiotensin System Inhibitors are Not Associated with Severity or Mortality in Hospitalized Patients with Coronavirus Disease (2 other studies on the subject)

 


Consensus Statement on Fundamental Concepts in Perioperative Fluid Management

30 Apr, 2020 | 03:51h | UTC

Perioperative Quality Initiative (POQI) consensus statement on fundamental concepts in perioperative fluid management: fluid responsiveness and venous capacitance – Perioperative Medicine

 


Podcast: Kidney Transplant for the Internist

28 Apr, 2020 | 04:16h | UTC

#210 Kidney Transplant for the Internist – The Curbsiders Internal Medicine Podcast

See also: Episode List

 


[Abstract Only] Meta-Analysis: Delayed vs. Early Initiation of Renal Replacement Therapy for Severe Acute Kidney Injury

26 Apr, 2020 | 21:15h | UTC

Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-analysis of randomised clinical trials – The Lancet

 


Potassium Enriched Salt Substitution Could Prevent a Large Number of Cardiovascular Deaths

23 Apr, 2020 | 09:27h | UTC

Estimated population wide benefits and risks in China of lowering sodium through potassium enriched salt substitution: modelling study – The BMJ

Commentaries: Salt substitution could prevent almost half a million deaths from CVD in China – George Institute for Global Health AND Embracing salt substitutes could help China prevent 450K CVD deaths per year – Cardiovascular Business

 


New EULAR Recommendations for the Management of Lupus Nephritis

8 Apr, 2020 | 01:16h | UTC

2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis – Annals of Rheumatic Diseases

Commentary: EULAR, ERA–EDTA issue guidelines for managing lupus nephritis – Medicine Matters

Related Guidelines: Consensus of the Brazilian Society of Rheumatology for the diagnosis, management and treatment of lupus nephritis (free) AND 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus (free) AND 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus (free) AND Clinical Practice Guidelines for the Treatment of Systemic Lupus Erythematosus by the Mexican College of Rheumatology (free) AND The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults (free) AND First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus (free) AND Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus (free PDF)

Related Reviews: Update on Lupus Nephritis – Clinical Journal of the American Society of Nephrology (free) AND Immunosuppressive Treatment for Proliferative Lupus Nephritis – Cochrane Library (free) AND Induction and Maintenance Immunosuppression Treatment of Proliferative Lupus Nephritis: A Network Meta-analysis of Randomized Trials. – American Journal of Kidney Diseases (free)

 


Study: Saline vs. Lactated Ringer’s Solution in Surgical Patients

7 Apr, 2020 | 04:11h | UTC

Saline versus Lactated Ringer’s Solution: The Saline or Lactated Ringer’s (SOLAR) Trial – Anesthesiology

 


COVID-19 and Renin-Angiotensin System Blockers

30 Mar, 2020 | 02:00h | UTC

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers – Hypertension AND Commentary: COVID-19 alert: Heart and kidney patients should keep taking their medicines – University of Miami Miller School of Medicine

Related Guidelines: HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19 – American College of Cardiology AND The Renal Association, UK position statement on COVID-19 and ACE Inhibitor/Angiotensin Receptor Blocker use AND Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers – European Society of Cardiology

Related Article: Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System—a Call for Epidemiologic Investigations – Clinical Infectious Diseases

 


NICE COVID-19 Rapid Guideline: Dialysis Service Delivery

23 Mar, 2020 | 01:30h | UTC

COVID-19 rapid guideline: dialysis service delivery – National Institute for Health and Care Excellence (free)

See also: COVID-19: Updates for Nephrologists (free resources)

 


Stay Updated in Your Specialty

 

No spam, just news.